Saizen®
Saizen® (somatropin for injection) is a recombinant human growth hormone made by DNA technology which is therapeutically equivalent to the natural growth hormone (GH) produced by the body.
Saizen® is indicated for the treatment of growth hormone deficiency (GHD) in children and adults, Turner's syndrome, and chronic renal failure and children born short for gestational age (SGA). Treatment of GH deficient children with Saizen® leads to accelerated growth. The overall effect of GH therapy in GHD children who respond well is that, as adults, they will be taller than they would have been if left untreated.
The role of GH in the human body:
Growth hormone (GH) is a protein produced by the pituitary gland, which is situated under the hypothalamus of the brain. This hormone controls children's growth and regulates a number of metabolic and physiological processes throughout life. Saizen® works by replacing the GH the body normally produces.
The Saizen® Device Family: Merck Serono is committed to simplifying treatment by offering a family of easy-to-use drug delivery devices. This opportunity to choose the best solution for individual patients' needs is intended to increase convenience and improve adherence to GH treatment.
The Saizen® Device Family is composed of several innovative products:
| Disclaimer |
The information in this section is intended for Healthcare Professionals only. US residents should consult the EMD Serono, Inc. for information on products approved for sales in the United States of America. |
